Abiomed (NSDQ:ABMD) said it doesn’t believe that the Centers for Medicare & Medicaid Services is likely to bestow a national coverage decision for its Impella heart pump.
MedVentive
Diabetes: Text messaging program wins McKesson grant | Funding Roundup
Partners Healthcare’s Center won a research grant to pilot a text messaging program aimed at helping diabetic patients manage their condition.
The grant, provided by McKesson, was awarded to the hospital system’s Center for Connected Health.
The program, called Mobilizing for Health, targets under-served patients to study whether personalized text messages have an impact on clinical outcomes and physical activity in people with Type II diabetes, who are often obese and have low activity levels.
Covidien CEO gives away the keys to the corner office | Personnel Moves
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Stock bulletin: Hedge fund billionaire bets big on Orthovita | Funding Roundup
MedVentive taps Nancy Brown for CGO spot
MedVentive Inc. appointed Nancy Brown as chief growth officer.
Brown joined the Waltham, Mass.-based healthcare information technology provider from electronic medical records firm Athenahealth Inc. (NSDQ:ATHN) of neighboring Watertown, Mass.
Her new role includes heading MedVentive’s sales, marketing and business development as the company reconfigures its products to new U.S. healthcare legislation.
MedVentive’s $10 million Series C round includes Clarian Health
MedVentive revealed the names of two of the investors that took its over-subscribed Series C round to $10 million: Clarion Health Ventures and previous backer Core Capital Partners.
The Waltham, Mass.-based healthcare information technology provider closed the C round in February, according to regulatory filings that, at the time, didn’t name the investors.
New investor takes a $1 million stake in MedVentive
Financial backers continue to line up behind MedVentive Inc., with a new group ponying up $1 million for the Waltham, Mass.-based healthcare management company.
The new money lifts the total amount MedVentive has raised through its Series C round to $10 million. The company said in July 2009 that it had closed on $7.25 million in a round led by Excel Venture Management of Boston.
The additional funding was disclosed in securities documents filed Feb. 19, but did not identify the new investor.
MedVentive wraps up $9 million VC round
MedVentive Inc. put the final touches on a fund-raising effort begun last summer, closing on an additional $1.75 million for a total of $9 million in new venture capital.
The Waltham-based healthcare management software provider said in July that it had closed on the initial $7.25 million in a Series C round led by Excel Venture Management of Boston.